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OVER a wide range of ages, the mortality from various types of human cancer
rises approximately in proportion to a high power of the age, and Muller (1951),
Nordling (1953) and Stocks (1953) have independently suggested that this could
be accounted for if the development of cancer were the end-result of a series of
discrete cellular changes-such, for example, as would be produced by somatic
mutations.
In a previous paper we tested the hypothesis by examining separately the
relationship between age and mortality for cancer of several different sites in
men and in women (Armitage and Doll, 1954). As a result, we concluded that
several of the other principal epidemiological characteristics of human cancer
could also be accounted for if carcinogenesis were a complex process of six or
seven stages and the degree of exposure to the factors inducing the changes
from one stage to another varied, either with age or from one year to another.
In particular, the hypothesis could account for:
(1) The differences between the shapes of the curves relating mnortality
to age, observed for different sites;
(2) the long latent period observed after exposure to a carcinogen
before a tumour develops;
(3) clinical observations such as the failure of circumcision carried
out in adolescence to protect against cancer of the penis and
(4) the apparent linearity of the relationship between cancer incidence
and the concentration of the carcinogen to which the subject is exposed,.*
The hypothesis was, however, unsatisfactory in that there was no direct
experimental evidence to suggest that carcinogenesis was likely to involve more
than two stages.
If the incidence of cancer did, in fact, increase exactly in proportion to the
4th, 5th or 6th power of the age over the whole range of ages and the incidence
of cancer at each age was directly proportional to the concentration of the initial
carcinogen, it would be difficult to see how the facts could be explained by any
* It is realized that the relationship is not linear in all circumstances-particularly when the inci-
dence of cancer is high. There is, however, some evidence that the relationship can be linear at low
doses and the existance of such a relationship has been accepted as a working hypothesis.
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hypothesis other than one of the type described. The range of ages over which
the relationship holds is, however, limited and it is possible to deduce other
mathematical relationships which will lead to closely similar relationships between
mortality and age for this limited range. One such relationship can
be obtained by adopting a suggestion put forward by Platt (1955), and
adapting it to the theory that two-and only two-stages are required for the
development of the disease.
Platt suggested that the effect of the primary carcinogenic agent might be
to induce a change in a cell such that its cellular descendants multiplied at a
faster rate than the normal surrounding cells. If, then, "ageing" were regarded
as something that occurred as a result of prolonged asexual multiplication and
cancerous degeneration were one of the end-results of ageing, it would follow
that cancer would appear in the descendants of the changed cell sooner than in
the surrounding tissue, but only after a long latent period such as is commonly
observed. This suggestion can be adapted to a two-stage theory of carcino-
genesis by postulating that the first stage is the production of a change of the
type suggested by Platt (1955), that the faster rate of multiplication confers a
selective advantage on the "changed" cells, such that the size of the affected
clone relative to other normal clones continuously increases, and that the
appearance of clinical cancer follows the occurrence of a second, discrete event
which constitutes the second stage.
In the simplest case, in which the subject is exposed on two separate and unique
occasions to the effect of the two agents and the chance of inducing either change
is directly proportional to the doses of the agents, the resulting incidence of cancer
will beproportionaltod2nt where d2is the dose of the second promoting agent, and
ntis the number of" changed" cells present at a time t after exposure to the first
initiatingagent. Withthepassageof time,thenumberof"changed " cells present will
beproportional tothe dose ofthe initiating agent butwill also increase exponentially
at a rate which depends on the degree of advantage over the surrounding cells
conferred on them by their changed state, i.e. nt will be proportional to d1ekt,
where d1 is the dose of the initiating agent and k is a constant. Hence the final
incidence of cancer (I) will be proportional to
dld2ekt.
When, as is likely to be the case in normal life, the subject is exposed continuously
-or at least over a number of years-to both agents, the relationship is more
complex. It can be shown, however, that so long as the concentration of the
agents to which the subject is exposed remains constant the resulting incidence
of cancer will be directly proportional to both concentrations, at least as a first
approximation, and that over a considerable period of time the increase in
incidence with age will be closely similar to that postulated by the earlier
"multi-stage" hypotheses-that is to say the relationship between the logarithm
of the incidence and the logarithm of the age will be approximately linear (see
Appendix and Armitage and Doll, 1954).
The shapes of the curves relating incidence to age which are predicted by
this model are shown in Fig. 1, and the extent to which the hypothesis provides
a satisfactory explanation of the observed changes iri mortality for certain types
of human cancer is illustrated in Fig. 2-5. In the latter figures the predicted
shape of the curves relating incidence with age is compared with the actual
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mortality recorded in each sex for cancer of four sites, for all ages from 25 to
74 years. Data for older ages have been omitted, because the diagnosis of the
cause of death at these ages is relatively unreliable and the resulting mortality
rates may be seriously underestimated; data for younger ages have been omitted,
because the numbers ofrecorded cases at these ages are small and sampling errors
would be relatively large. Since the recorded data relate to age at death and
the hypothesis relates to age at which the cancer first appears, it is necessary to
subtract a time corresponding to the average interval between the time of first
appearance of the disease and the time of death. For simplicity this has been
v
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FIGa. 1.---Family of curves relating incidence of cancer to age which would be consistent
with the hypothesis: log (I/lNpl) is plotted against log (kt) for various values of p2/k
and the corresponding values of log10(p2/k) are shown next to each curve.
taken to be 21 years for each of the types of cancer considered; hence the
mortality corresponding to the age group 30 to 34 years, with a mean age of
321 years, has been regarded as being proportional to the rate of occurrence of
the disease at age 30 years.
The observed mortality data have been presented in two ways: in the first,
mortality data which were recorded during the period 1951-55 have been used;
in the second, mortality data have been plotted for a cohort of the population
born around 1881.* In fact there are no human data which are entirely suitable
for comparison with the model, since a population is required which has been
exposed to constant environmental conditions and to which standards ofdiagnosis
* The death rates used in the present study are those published by Case (1956a), except that
rates for the period 1951-55 have been substituted for the published rates for 1951-54 (Case, personal
communication). Cohort data are not given for ages 25 to 29 years as suitable data are not available
for years before 19]1, when persons bornr in 1881 were already aged 30 years.
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have been evenly applied. The second condition may be presumed to apply
approximately to data collected during the same period for the limited age range
of 25 to 74 years, but it is unlikely to apply to cohort studies of most types
of cancer, in which the mortality for different age groups is recorded at different
periods-as widely apart, in the present case as 1911 and 1955. On the other
hand persons of different ages dying at the same time have been exposed to
conditions oflife at different historical periods. This is to some extent overcome
by use of the cohort method (Case, 1956b) since comparisons are then made
between mortality rates of persons who have all been born in the same group of
years and who have all been subjected to the same conditions of life in youth.
Even so the requirement of constant environmental conditions will not be met
unless the degree of exposure to the carcinogenic agents remains constant
throughout the individual's life.
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FIIG. 2.-Comparison between the change in mortality with age recorded for cancer of the
stomach in men and in women and the shape of the curve predicted by the hypothesis: the
logarithm of the death rate per million persons plotted against the logarithm of the age less
2j years.
A. Mortality data recorded in 1951-55.
B. Mortality data for cohorts born around 1881.
X Male. O Female.
From Fig. 2-5 it appears that the mortality data recorded for cancer of the
stomach, intestines, rectum and pancreas in both men and in women can be
fitted reasonably closely by curves of the type predicted by the hypothesis.
The slight systematic discrepancies seen in the data for cancer of the pancreas
in the period 1951-55, and for cancer of the stomach in the cohort of men born
in 1881 may, perhaps, be attributed to (1) a commencing decline in the mortality
from the disease and (2) variation in the fashions of diagnosis. It is shown, in
the Appendix, that the curves which have been fitted to the data are obtained
on the assumption that the selective advantage given to the clone affected by
the initial carcinogen is such that the number of cells in the clone approximately
doubles every five years.
The types of cancer illustrated in the figures are those which are common
in both sexes and in which the mortality has been shown previously to increase
approximately in proportion to the 5th or 6th power of the age. Other common
types of cancer (i.e. cancer of the lung, bladder and prostate in men and cancer
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FiG. 3.--Change in mortality with age for cancer of the intestines
in men and in women, shown as in Fig. 2.
A. Mortality data recorded in 1951-55.
B. Mortality data for cohorts born around 1881.
x Male. O Female.
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FIo. 4.-Change in mortality with age for cancer of the rectum
in men and in women, shown as in Fig. 2.
A. Mortality data recorded in 1951-55.
B. Mortality data for cohorts born around 1881.
X Male. 0 Female.
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FIG. 5.-Change in mortality with age for cancer of the pancreas
in men and in women, shown as in Fig. 2.
A. Mortality data recorded in 1951-55.
B. Mortality data for cohorts born around 1881.
X Male. Female.
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of the breast and cervix and corpus uteri in women) are not illustrated because
the relationship between age and mortality is known to be more complex. The
way in which the relationship departs from that depicted in the figures can,
however, be explained without abandoning the present hypothesis. For the
three types of cancer in females the mortality at the higher ages falls below
that which would be expected, if the same assumptions were to be made as have
been made previously. Cancer of the cervix uteri provides the most extreme
case in which the mortality increases very slightly above age 60 years.
Cancer of the Cervix Uteri, 1951-55
Age in years
C-
25- 30- 35- 40- 45- 50- 55- 60- 65- 70-74
Death rate per million . 10 30 58 93 136 203 254 285 304 315
These observations could be accounted for if it were postulated that the selective
advantage of the clone of changed cells was hormone dependent and that the
advantage was consequently decreased following the menopause. Conversely,
the steep increase in mortality recorded for cancer of the prostate in men could
be accounted for if the selective advantage of the clone was increased in and
after middle age. The relationships between mortality and age for cancers of
the lung and bladder are further complicated by changes in the prevalence of
causal factors in the environment and-in the case of lung cancer-by gross
changes in diagnostic techniques. These types of cancer may be regarded as
special cases and are, therefore, not considered for the purpose of the present
discussion.
With the present hypothesis, it is also possible to account for those other
observations which, it has been pointed out, could be accounted for by a multi-
stage mechanism for the induction of the disease.
Firstly, the long latent period often observed after exposure to the effective
carcinogen and before the clinical appearance of the disease would be expected
for the same reason that the mortality of the disease is expected to be low in
young persons and high at older ages. It is also clear that some cases with short
latent periods would be expected to occur-as, in fact, they do. Whether the
decrease which is observed in the frequency of cases with very long latent periods
can be accounted for by the decrease in the population at risk cannot be tested,
however, as the available data are insufficient.
Secondly, it is shown in the Appendix that, for small values ofpl, the incidence
at any given time t after exposure to the initiating carcinogen is
Np1 {1 - exp[p~~ P2 (ekt - 1)])
where Pi is the probability per unit of time that a normal cell will undergo the
first change, P2 is the probability per unit of time that a cell in the clone of cells
affected by the first change will undergo the second, N is the mean number of
cells per person exposed to the initial carcinogen and k is a constant. Iftherefore,
P1 is proportional to the dose of the initiating carcinogen, it follows that, so
long as the final incidence is small, the incidence of the disease at a given age
will be proportional to the doses of the carcinogen to which the subject was
initially exposed.
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In the authors' opinion, the above arguments do not prove that the hypothesis
which has been put forward is true. The nature of the relationship between
incidence and age cannot be known exactly and the data which have been con-
sidered could be explained in other ways. What has been shown, however,
is that the human mortality data are consistent with the theory that the induction
of cancer takes place in two stages-one or both of which could be of the nature
of a somatic mutation.
SUMMARY
The theory that cancer is induced in two stages can be extended to include
the postulate that the first stage results in the production of a clone of cells
which have a slight selective advantage over the surrounding and unaffected
cells.
With this added postulate, it is possible to show that the incidence of cancer
to be expected at all ages between 25 and 74 years could be close to the mortality
actually recorded for cancer of the stomach, intestines, rectum and pancreas in
both sexes. The expected incidence could also be close to the recorded mortality
from cancer of the breast, and cervix and corpus uteri in women and from cancer
of the prostate in men, if it was further postulated that the selective advantage
was hormone dependent.
With the first postulate it is, at the same time, possible to account for those
other epidemiological facts which have previously been accounted for on the
basis of a multi-stage mechanism for the induction of the disease, namely:
(1) The long latent period often observed after exposure to the carci-
nogen and before the appearance of the disease and
(2) the existence, at low incidences, of a linear relationship between
the incidence of cancer at a given age and the concentration of the initial
carcinogen.
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APPENDIX
Suppose that
(i) the probability is Pi per unit time that any normal cell undergoes
a first change, where Pi is proportional to the concentration, dl, of the
agent initiating the first change;
(ii) each cell which has undergone a first change gives rise to an ex-
ponentially increasing clone, containing ekt cells at a time t after the
first change;
(iii) any such clone which has not yet experienced a second change
has a probability p2ekt per unit time of doing so, where P2 is proportional
to the concentration, d2, of the agent initiating the second change.
A second change will occur in a clone at time t only if the clone originated
from a first hit at some previous time t - T, and if no previous second changeP. ARMITAGE AND R. DOLL
has taken place in the interval (t - T, t). The probability that a second change
takes place during a short interval (T, T + dt) after the formation of the clone,
and not earlier, can be shown, from (iii), to be
e(P2 (-ekT) P2 ekT dt (1) expr k (1 -) pd
The probability that the first change takes place in a short interval (t T,
t - T + dT) is, from (i),
Ple-Pi(t-T) (dT
which, for small values ofPl, is approximately equal to
pi dT . . . . . (2)
Hence, the probability that the first change takes place in (t - T, t T + dT),
and the second change in (t, t + dt) and not earlier, is the product of (1) and (2):
Pl P2 exp(p2/k) . exp kT - P ekT) dT dt. . . (3) k
Hence, the total probability, ydt, that a single cell or its descendants experience
a second hit in the interval (t, t + dt) is obtained by integrating (3) with respect
to T:
t
ydt = Pl Pexp(p2/k) dt f exp (kT - k ekT dT
0
i.e.
Y =Pl exp[- 2(ekt1)]. . . . . (4)
The incidence rateper person, I, is obtained by multiplying (4) by N, the mean
number of cells per person which are exposed to the risk of a first hit; i.e.
I Npl I -l exp[- k (ek- - 5)
For small values oft, (5) gives the asymptotic result
I Nplp2t.
This is the result previously obtained (Armitage and Doll, 1954) for a two-stage
process with constant probabilities. The equivalence is not surprising, since
for small t the exponential function p2ekt of (iii) tends to the constant value P2.
For infinitely large values of t, (5) gives the asymptotic result
I - Np1.
The same upper limit, Np1, for the value of I is strictly required by the multi-
hit model with constant probabilities previously considered (Armitage and Doll,
1954). The usual formula giving I as a power function of t is valid only for
small values of t.
From (5) it may be seen that I/Npl is a function only ofp2/k and kt. Fig. 1
shows a family of curves relating log (I/Np1) to log (kt) for various values of
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p2/k. SinceI/Npl and kt areproportional to incidence (I) and age (t),respectively,
the shape of each curve with this double logarithmic transformation is exactly
the same as that of the corresponding curve relating log I to log t. It will be
seen that the maximum slope of the curves increases as p2/k decreases. Each
curve exhibits slight positive curvature until shortly before the upper limit
is reached.
To fit (5) to observed data by objective methods would be rather troublesome,
and, as has been stated earlier, available data are too difficult to interpret to
make any elaboration worth while. Over a range ofabout 0 4 to 0 5 logarithmic
units in t, the steepest portions of the curves forp2/k = 10-3'5 and 10-4 have an
overall slope of about 5 5 and 6.0, respectively, values which accord fairly well
with the observed data. In Fig. 2 the curves forP2/k 10-4, 10-3'5 or (in one
instance) 10-3 have been fitted by eye to the observed data for various sites,
the choice between the different values of p2/k being purely empirical. Syste-
matic deviations from the fitted curves certainly exist, but the general degree
of agreement is no worse than would be obtained by fitting straight lines. Better
fits would sometimes have been obtained by a less restrictive choice of p2/k.
From (5), for small values ofp2(ekl - 1)/k,
, Np1P2 (ekt 1).
Hence except for values of t large enough to bring I near to its upper limit, the
value of I is hardly affected when Pi is multiplied by any factor greater than
unity, and P2 is divided by the same factor, k remaining constant. (We must,
however, avoid increasing Pxto such an extent that the approximation (2) is
invalid.) We may therefore hope, if the model is correct, to be able to estimate
k and the product Nplp2, but not N, Pi or P2 separately.
Table I shows the value of p2/k chosen for each site, and the estimates of k
and Nplp2. The values of k are fairly uniform, with an average value of 0 13,
which (if the theory is correct) would imply that first-hit cells had sufficient
selective advantage to double in number about every five years.
TABLE I.-Estimated Values of Constants Obtained by Empirical Fit of Theoretical
Curve to Observed Data
Value of
log10(p,/k) Estimate of
for fitted r
Site Sex curve k log10(Nplp2) Stomach (1951-55) M. -3-5 . 012 -7.26
F. -40 . 0-15 -7-51
,, (1881 cohort) . M. -3.5 . 0-13 -7-07
F. . ---35 . 0 13 -7-23
Intestine (1951-55) M. . -3.5 . 0.11 -7-14
F. . -3-5 . 0.11 -7-14
,, (1881 cohort) M. -3.5 . 013 -7-25
F. . -3'5 0 13 --7-34
Rectum (1951-55) . M. . -4-0 . 014 -7 72
F. . --3.5 . 0-13 -7-65
,, (1881 cohort) . M. . -3.5 0-12 -7.22
F. . -3.0 . 0.11 -7.21
Pancreas (1951-55) . M. . -3-5 0 13 -7-73
F. -4.0 . 014 -8-29
,, (1881 cohort) . M. . -4-0 . 0.15 -8-14
F. . -4-0 . 0.15 -9- 34
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